A short 2 ½ minute video with Dr. Joshua Helman, Harvard MD.
It’s not a start up. It’s a roll out.
ATCA is not a start-up, it’s a roll out and it is ready to scale. There is no more R & D to prove out (IT ALREADY WORKS). The first clinic is already built in Atlanta, GA and equipped with $1.5 MM in modalities and nutraceuticals. Alpha testing, Beta testing, R & D testing, and Marketing testing have all been successfully accomplished. We are in-network with Medicare and all major insurance and have been paid.
The initial clinic has been constructed and equipped.
We are now in the process of transitioning to a brick-and-mortar setup, preparing to hire staff, implement marketing strategies, and scale up a 17,000 sq. ft. clinic in Atlanta. Successful alpha and beta testing have been completed.
We have invested $1.5 million in onsite treatment tools. Additionally, there is a nutraceutical store onsite, along with a 20-chair infusion center.
Who We Are
An accomplished team of MBA graduates, including 6 from Harvard, 1 from Duke, 1 from Michigan, 1 from Wharton, and 1 from Copenhagen.
A distinguished medical team featuring 2 doctors from Harvard, alongside physicians from Oxford, Columbia, Ohio State, Meharry, and a neurologist trained in functional medicine.
We’ve onboarded three world-class influencers in our niche for strategic marketing, tapping into their extensive reach on social media to amplify our impact.
Our seasoned management team is led by Greg Buckley (HBS) who has run billion-dollar companies including Medical Businesses, Progressive Auto Insurance, PepsiCo and Gibson Guitars.
Introducing our dynamic leadership team, uniting business acumen with medical expertise. This powerhouse group is driving innovation in AI-enabled Alzheimer’s treatment, passionately committed to transforming healthcare for those affected by this challenging condition.
Greg Buckley - CEO
Greg Buckley holds an MBA from Harvard Business School and a BSME from the University of Michigan. As the former CEO of Progressive Medical, he achieved an outstanding 330% revenue growth in just four years.
During his tenure as President of Progressive Insurance Company, Greg played a pivotal role in scaling revenue from $20 million to $150 million and boosting profits from $2 million to $43 million over a four-year period.
Previously Greg served as VP at PepsiCo’s Pizza Hut, where he played a key role in overseeing the operation and growth of 1,500 locations opening 100+ new stores in a two year period. Greg understands scale and has deep expertise in growing location-based businesses.
Dr. Joshua Helman - Chief Medical Officer
Dr. Joshua Helman MD is a Harvard-trained physician licensed in fourteen states. He has two degrees in Biochemistry, (Bachelor’s from Harvard magna cum laude and Master’s from the University of Cambridge, UK).
He is double Board Certified by the American Board of Emergency Medicine and American Board of Lifestyle Medicine. His medical degree is from Harvard Medical School and MIT.
He is the former Medical Director of Hippocrates Health Institute, was on the TrueNorth Health Center research team and was affiliated with Sponaugle Wellness Institute for 6 years, helping to reverse and prevent dementia. His areas of interest include Alzheimer’s disease, vitality, longevity, toxins, mold, Lyme disease and fasting
Michael Spicer - Chief Financial Officer
Harvard Business School
40+ year career in finance, accounting and operations management, primarily as a CFO and COO. Raised between $200MM and $300MM in equity and debt financing.
COO: Wiggins & Dana LLP
CFO: NovaDel Pharma (NVD) – Raised $37MM in Private Placements of Equity.
CFO: Orchid Biosciences Inc. – Raised $45MM in IPO & Private Investments and Bank Loans.
Douglas Collins - Director of Business Development & Investor Relations
Director of Business Development & Investor Relations
Co-Author of the best-selling book Truth, Lies & Alzheimer’s – Its Secret Faces sharing tips for navigating the challenges of Alzheimer’s and their loved ones/caregivers.
Collins is an internationally respected business strategist.
He had the first Video Over IP (VoIP) broadcast studio in Scottsdale, AZ where he developed a sphere of influence with major media.
He has had helped several companies move to exit strategies including GoPublic Transactions and Acquisition.
Meet CEO Greg Buckley and Director of Business Development Douglas Collins in Atlantic City, NJ and learn about how AI + Personalized Precision Medicine is being used for the treatment of Alzheimer’s, dementia, memory loss, and brain fog from Long COVID.
January 30, 31, February 1, 2024
Caesars Atlantic City Hotel & Casino
Join the revolution in Alzheimer’s treatment! Invest for impact at our online event – “Investing For Impact: AI’s Role in the Fight Against Alzheimer’s,” hosted by Alzheimer’s Treatment Centers Of America on Jan 24th.
Explore how AI precision medicine is transforming Alzheimer’s treatment. If you’re an accredited investor passionate about making a difference, don’t miss this chance!
How AI Revolutionizes the Treatment of Alzheimer’s and Dementia
Learn How Alzheimer’s Treatment Centers of America uses Artificial Intelligence (AI) in the treatment of Alzheimer’s and dementia..
Offering 50+ Modalities
- Infared saunas
- Cryotherapy Chamber
- Sleep Apnea devices
- IV Center
- Magnetic Energy
- Hyperbaric Chamber
- Ozone Therapies
- Laser Light Energy
- Brain Mapping & Biofeedback
- BrainEx Neurostimulation
- Many more
Want to learn more?
Accredited Investors Only | Convertible Note with 12% PIK | $50,000 Minimum Investment
We’d love to help you learn more about our revolutionary Artificial Intelligence Protocol + Personalized Precision Medicine for the treatment of Alzheimer’s, dementia, memory loss and brain fog from Long COVID. Fill out the form below and we’ll share our full investor presentation, where we go through our business and future plans in detail.
Alzheimer’s Treatment Centers of America has built out our CONSUMER WEBSITE where we can schedule new clients and much more.
The information on this web site is provided for informational purposes only, is not comprehensive, does not contain important disclosures and risk factors associated with any investment, and is subject to change without notice.
© Alzheimer Treatment Centers of America, all rights reserved.